Champagne corks are popping at Berlin start-up Medwing as the fledgling medtech company took in EUR 28 million in series B funding. The investors were led by Cathay Capital from San Francisco – it’s the first time Cathay has invested in a German company. Also involved are the VCs Northzone, Cherry Ventures and Atlantic Labs.
The future looked bleak for Halberstadt in the federal state of Saxony-Anhalt – a city dependent on a dying industry. Then it became one of eastern Germany’s “model cities for reconstruction” and developed into a hub for medical technology.
Migraines seriously reduce the quality of life for millions of people, and there is unfortunately no cure. Berlin start-up Newsenselab, however, has developed an app called M-sense that helps migraine sufferers better manage their condition.
Teledermatology is becoming popular Germany. The prize-winning Swiss sector leader OnlineDoctor has expanded its services, partnering with the Professional Association of German Dermatologists and attracting more than 150 physicians to its Internet platform “online doctor”.
Researchers in Penzberg, Bavaria have developed the test for Swiss pharmaceutical company Roche that is being hailed as a “milestone” in the fight against the corona-virus.
In the global efforts to combat the coronavirus pandemic, testing has proven to be a main challenge.
Stem cells are a vital element in biotechnology research, but so far they have been difficult to mass produce. Dresden start-up denovoMATRIX wants to change all that.
With the entire world looking for responses to the coronavirus pandemic, Germany’s pharmaceutical companies are attracting considerable attention. We asked Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies, for an update on the progress in developing anti-corona medications.
The health care division of world-renowned German company Bosch announced on March 26 that it has developed a test kit for COVID-19 and nine other viral respiratory illnesses.
German companies are at the heart of the emergency development of potential coronavirus vaccines. That’s no accident considering Germany’s importance in both the pharmaceutical and biotechnology sectors. Germany Trade & Invest Director of Chemicals and Health Marcus Schmidt gives us the lowdown on this crucial area.
